close

Products

Date: 0000-00-00

Type of information: Licensing agreement

Product name: Product name:lknk

Compound: knjnlnlnln

Therapeutic area: n

Action mechanism: lnl

Company: nl

Disease: nl

Latest news: nln

Patents: l

Submission of marketing authorization application USA : nl

Submission of marketing authorization application UE: nl

Withdrawal of marketing authorization application USA: n

Withdrawal of marketing authorization application UE: ln

US authorization: ln

UE authorization: ln

Favourable opinion UE: l

Favourable opinion USA: nl

Orphan status USA: nl

Orphan status UE: n

Pediatric exclusivit _USA: ln

Pediatric exclusivity UE: ln

OTC status: ln

Other news: l

Is general: No